Primaquine Phosphate Tablets: A Critical Lever in Malaria Elimination

Primaquine phosphate tablets have emerged as a high-value component in modern malaria control, serving as the definitive radical cure for Plasmodium vivax and P. ovale infections and as a gametocytocidal tool to curb transmission. The current trend in elimination programs elevates the role of primaquine beyond treatment-relying on rapid, accurate G6PD testing and well-coordinated case management to unlock its full potential. Yet its safety profile, particularly the risk of hemolysis in G6PD-deficient patients, demands rigorous pharmacovigilance and health-system readiness. In this context, supply reliability and quality control are as crucial as pharmacology.

From the manufacturing floor to the point of care, the industry faces a triple mandate: deliver consistent quality, meet fast-moving demand, and navigate diverse regulatory landscapes. Harmonized guidelines on testing, labeling, and packaging reduce risk, while robust supplier auditing and anti-counterfeit measures protect program integrity. Price, shelf-life, and cold-chain considerations shape procurement decisions in endemic regions, where public and philanthropic buyers increasingly demand transparent traceability. As generic producers expand capacity, partnerships with national malaria programs and donors become essential to sustain access without compromising safety.

Looking ahead, the value of primaquine hinges on integrated health systems: scalable G6PD testing, clinician education, and clear national guidelines that balance relapse prevention with safety. Stakeholders should discuss equitable access for underserved communities, inclusion of pregnant women and children under specialist supervision, and strategies to monitor and report adverse events in real time. The conversation is also about data-driven procurement, supply chain resilience, and continued R&D to optimize dosing strategies and combination regimens that preserve efficacy while minimizing risk. Your thoughts on actionable pathways are welcome. 

Read More: https://www.360iresearch.com/library/intelligence/primaquine-phosphate-tablets

Scroll to Top